Definiens at MMTC


Visit Us at Booth #512

Learn about these exciting innovations 


Redefine the “one CDx – one treatment” paradigm

  • Apply a harmonized baseline set of actionable biomarkers from translational research through early & late stage clinical
  • Add spatial and functional information of the immune-landscape to gain unique insights.
  • Combine immune-profiling data from various programs to accelerate clinical decisions.


Our Insights redefine biomarker programs. Leverage your biomarker data seamlessly from early research into next generation clinical diagnostics.

Insights Services

Modular or customized Biomarker Profiling and Data-Mining interpreted by a unique team of scientists, biostatisticians, clinicians & pathologists


Expert support for your biomarker strategy, clinical trial design and CDx market access.

Definiens Insights Portal enhances collaboration with internal and external stakeholders, secure data-access and -governance.

Regulatory Services

Definiens regulatory expertise addresses changing regulatory requirements.

Insights Portal easy collaboration around the globe

Our Insights are available through an innovative web-based portal which serves as a central collaboration tool and data repository. This portal facilitates seamless data and image exchange between CROs, laboratories, trials sites, and your Definiens experts. 

  • Consolidate all project information (digital images, result data, reports, and more) in one central space for improved & accelerated collaboration
  • Benefit from full transparency along the course of your projects with respect to status of image data and result delivery, allowing you fast and direct Insights generation
  • Apply data governance across programs & use a central data repository in compliance with strict security & data-safety standards including a customizable audit-trail functionality

Poster Presentation & Scientific Talks

Join our thought leaders for these  dynamic presentations. 

Poster Presentations 

  • What you (Q)C is what you get – A robustness check for image analysis readouts
  • Combining Immunophenomics with a Gene Expression Panel to Deepen the Understanding of Prostate Cancer 

Monday February 12 from 4:10 - 4:25

Standardized Profiling of the Immune Status based on Spatial & Functional Characterization of the Tumor Microenvironment

Characterization of the immune status of patients becomes increasingly important to personalize cancer treatments. We developed a standardized multiplex immunohistochemistry assay (IO-panel) to profile the immune status of patient tumors into biologically meaningful and clinically actionable categories using next generation image mining and data analysis tools.

Guenter Schmidt, Ph.D., Vice President, Definiens AG

View on MMTC Site

Wednesday February 14 from 2:30 - 3:30

PANEL DISCUSSION: AI vs. Medical Doctor 

AI is simply a tool – not a replacement for the physician. Deep learning can be applied to numerous diagnostic tasks and defines a new era in digital pathology. This session will focus on advancements in AI in surgical pathology and what the use of this technology means for the future of the practice of pathology.

  • Understand basic definitions of AI and deep learning
  • Review applications and use cases to date within medicine and pathology
  • Discuss implications of AI for practice of pathology
  • Highlight potential opportunities and weaknesses for AI within pathology

Moderator: Keith J. Kaplan, M.D., Pathologist, CMO, Corista LLC; Publisher, Tissuepathology.Com

Doug Bowman, VP, Pharma Services, Indica Labs
Patricia Goede, Ph.D., Vice President, Clinical Informatics, XIFIN, Inc
Dan Hosseinzadeh, CEO, Pathcore; Co-Chair, DICOM Pathology Working Group
Paul O’Reilly, Ph.D., Head of Research, Image Analytics; Philips Digital Pathology Solutions
Liron Pantanowitz, M.D., Professor, Pathology & Biomedical Informatics, University of Pittsburgh Medical Center
Guenter Schmidt, Ph.D., Vice President Research, Definiens AG

View on MMTC Site

Contact Us